CLGN · NASDAQ
CollPlant Biotechnologies (CLGN) Stock Price & Fundamentals
CollPlant Biotechnologies (CLGN) closed at $612.36 on Oct 9, 2026, up 0.37% from the previous close of $610.09.
Share price, past year
1Y −7.19%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $612.36 |
| Sep 30, 2026 | $615.91 |
| Aug 31, 2026 | $609.32 |
| Jul 31, 2026 | $610.07 |
| Jun 30, 2026 | $614.78 |
| May 29, 2026 | $594.27 |
| Apr 30, 2026 | $601.66 |
| Mar 31, 2026 | $613.59 |
| Feb 27, 2026 | $671.64 |
| Jan 30, 2026 | $650.57 |
| Dec 31, 2025 | $624.51 |
| Nov 28, 2025 | $640.58 |
| Oct 31, 2025 | $665.52 |
Key statistics
- Market cap
- $7.84B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- —
- Shares outstanding
- 12.8M
- Dividend yield
- —
- 52-week range
- $579.91 – $692.16
CollPlant Biotechnologies's market cap is $7.84B, based on a share price of $612.36 and 12.8M shares outstanding as of Dec 31, 2025.
Financials
CollPlant Biotechnologies reported revenue of $2.37M for fiscal 2025, up 360.39% from fiscal 2024.
CollPlant Biotechnologies reported a net loss of $11.49M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $2.37M | +360.4% | −$11.49M | −484.6% | −$0.94 | −$9.45M |
| FY2024ended Dec 31, 2024 | $515.00K | −95.3% | −$16.61M | −3,225.1% | −$1.45 | −$14.58M |
| FY2023ended Dec 31, 2023 | $10.96M | +3,565.2% | −$7.02M | −64.1% | −$0.62 | −$3.72M |
| FY2022ended Dec 31, 2022 | $299.00K | −98.1% | −$16.93M | −5,660.5% | −$1.53 | −$14.97M |
| FY2021ended Dec 31, 2021 | $15.64M | +154.9% | $237.00K | 1.5% | $0.02 | $1.07M |
| FY2020ended Dec 31, 2020 | $6.14M | +164.8% | −$5.77M | −94.1% | −$0.84 | −$4.89M |
| FY2019ended Dec 31, 2019 | $2.32M | −53.8% | −$11.16M | −481.6% | −$2.23 | −$7.19M |
| FY2018ended Dec 31, 2018 | $5.01M | — | −$6.25M | −124.6% | $1.43 | −$2.05M |
Company profile
- Name
- CollPlant Biotechnologies Ltd
- Ticker
- CLGN
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- 4 Oppenheimer St., 11th Floor, Rehovot, L3 74140
- Incorporated in
- L3
- Fiscal year ends
- December
- SEC CIK
- 0001631487
Frequently asked questions
What is CollPlant Biotechnologies's stock price?
CollPlant Biotechnologies (CLGN) closed at $612.36 on Oct 9, 2026, up 0.37% from the previous close of $610.09.
What is CollPlant Biotechnologies's market cap?
CollPlant Biotechnologies's market cap is $7.84B, based on a share price of $612.36 and 12.8M shares outstanding as of Dec 31, 2025.
How much revenue does CollPlant Biotechnologies make?
CollPlant Biotechnologies reported revenue of $2.37M for fiscal 2025, up 360.39% from fiscal 2024.
Sources and methodology
Fundamentals come from CollPlant Biotechnologies Ltd's filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures